Functional & Movement Disorders Ataxia means ”a lack of order”; people with ataxia experience a failure of muscle control in their arms and legs, resulting in a lack of balance and coordination or a disturbance in their gait. Ataxia may also affect the movement of your fingers, hands and entire body, and it may also compromise your speech and alter your eye movements. Ataxia results when cells in the cerebellum degenerate or atrophy; the spine and the peripheral nerves that connect the spine to the cerebellum may be affected too. The symptoms and time of onset of ataxia vary according to the underlying cause of the disease and type of ataxia you have (and with the inherited forms, can vary from person to person even with the same type of the condition). The most common symptoms of ataxia across all forms include loss of balance and coordination, slurred speech, slow eye movement, difficulty in swallowing and trouble with walking. The loss of balance can interfere with your ability to stand and walk and the loss of fine motor control can make writing and eating a trying task.
Ataxia occurs when the nerve cells in the cerebellum (the part of your brain that controls motor function) suffer damage, degeneration or death. Ataxia can be acquired as a symptom of another condition, inherited through variants of a number of genes or appear without a verifiable cause (also known as sporadic ataxia). Acquired ataxia conditions include trauma or injury to the brain or spinal cord , stroke, a transient ischemic attack (TIA), cerebral palsy, multiple sclerosis (MS), the chickenpox virus, tumors in the cerebellum, paraneoplastic syndromes (rare, degenerative disorders caused by your immune system’s response to cancerous tumors), a toxic reaction to medications, drugs or chemicals (especially barbiturates, sedatives, heavy metals, solvents, alcohol and recreational drugs) and a deficiency in vitamin E or B-12. Hereditary ataxia occurs when you inherit either a dominant gene variant from one parent (called autosomal dominant ataxia) or a pair of recessive gene variants from both parents (autosomal recessive ataxia).
The autosomal dominant form includes the spinocerebellar ataxia group, a progressive degenerative condition that may be caused by 1 of 20 identified genes. Some symptoms, as well as age of onset, differ depending on the gene mutation involved. This group is also represented by episodic ataxia (in which the episodes are triggered by stress and sudden, startling movements. Seven versions of this type of ataxia exist, labeled as EA1 through EA7. Some of these forms resolve on their own in later life and the symptoms may respond to medication. The autosomal recessive form includes Friedreich's ataxia (a common, progressive form of hereditary ataxia), ataxia-telangiectasia (a rare, progressive form that appears in childhood), congenital cerebellar ataxia (damage to the cerebellum at birth) and Wilson disease (caused by the accumulation of copper in brains, livers and other organs). Sporadic ataxia may appear in a number of forms, including multiple system atrophy. At Houston Methodist, we will evaluate your medical and family history and perform a neurological examination, including an MRI scan (magnetic resonance imaging).
Our team may recommend various blood tests to discover or rule out other possible disorders that may present similar symptoms. Genetic blood tests are now available for some types of hereditary ataxia to confirm a diagnosis or as a predictive test to determine if someone has inherited an ataxia gene known to affect other family members. Treatment Options for Ataxia Although there is no cure for a hereditary ataxia, an ataxia caused by another condition may be cured by treating the underlying condition. For example, ataxia caused by a metabolic disorder may be treated with medications and a controlled diet; ataxia due to vitamin deficiency is treated with vitamin therapy. A variety of drugs may be used to either effectively prevent ataxia symptoms or reduce the frequency with which they occur. Physical therapy can strengthen muscles, while special devices or appliances can assist in walking and other activities of daily life. Ataxias are complex disorders that require a comprehensive approach by specialists devoted to their evaluation and management.
The comprehensive team approach we take at Houston Methodist involves experienced neurologists, neurosurgeons, neuropsychologists, physical therapists, speech therapists and others as appropriate. We use the latest treatment and in technology and diligently listen to our patients and their families. Our team evaluates and treats all these aspects in order to maximize the quality of our patients' lives. Our physicians at Houston Methodist specialize in managing ataxia at the following convenient locations:Please, wait while we are validating your browserdi Salvo ML, Contestabile R, Safo MK. Vitamin B(6) salvage enzymes: mechanism, structure and regulation. Vasdev S, Ford CA, Parai S, et al. Dietary vitamin B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Yu CZ, Liu YP, Liu S, et al. Systematic administration of B vitamins attenuates neuropathic hyperalgesia and reduces spinal neuron injury following temporary spinal cord ischaemia in rats. Zhang P, Suidasari S, Hasegawa T, et al. Vitamin B(6) activates p53 and elevates p21 gene expression in cancer cells and the mouse colon.
Oncol Rep. May 2014;31(5):2371-2376. Murakami K, Sasaki S, Uenishi K, et al. Higher intake of vitamin B-6 and dairy products and lower intake of green and oolong tea are independently associated with lower serum homocysteine concentration in young Japanese women. Nutr Res. Aug 2013;33(8):653-660. Song Y, Cook NR, Albert CM, et al. Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Cui R, Iso H, Date C, et al. Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study. van Uffelen JG, Chinapaw MJ, van Mechelen W, et al. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br J Sports Med. May 2008;42(5):344-351. LeBlanc KE, Cestia W. Carpal tunnel syndrome. Sharma S, Litonjua A. Asthma, allergy, and responses to methyl donor supplements and nutrients.
J Allergy Clin Immunol. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. Festin M. Nausea and vomiting in early pregnancy. Masino SA, Kahle JS. Vitamin B6 therapy during childbearing years: cause for caution? Larsson SC, Giovannucci E, Wolk A. Vitamin B6 intake, alcohol consumption, and colorectal cancer: a longitudinal population-based cohort of women. Theodoratou E, Farrington SM, Tenesa A, et al. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. Jan 2008;17(1):171-182. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. Eussen SJ, Vollset SE, Hustad S, et al. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. Jan 2010;19(1):28-38.
Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, et al. Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. Lin J, Lee IM, Cook NR, et al. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr. Zhang SM, Cook NR, Albert CM, et al. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. Wu W, Kang S, Zhang D. Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis. Kang YK, Lee SS, Yoon DH, et al. Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study. von Gruenigen V, Frasure H, Fusco N, et al. A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients. Braik T, Yim B, Evans AT, et al. Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy.
J Community Support Oncol. Zhou Y, Peng L, Li Y, et al. Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis. Biomed Rep. Nov 2013;1(6):873-878. Chen M, Zhang L, Wang Q, et al. Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review. Corrie PG, Bulusu R, Wilson CB, et al. A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. Rostock M, Jaroslawski K, Guethlin C, et al. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013;2013:349653. Kulkantrakorn K. Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited. Neurol Sci. Jul 24 2014. Foods high in B vitamins may lower cardiovascular risks. Folate and vitamins B6 and B12 appear to be beneficial, but supplements should be taken only when recommended by a doctor.
Sharma S, Sheehy T, Kolonel LN. Ethnic differences in grains consumption and their contribution to intake of B-vitamins: results of the Multiethnic Cohort Study. Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis. Apr-Jun 2006;29(2-3):317-326. Halsted CH, Medici V. Vitamin-dependent methionine metabolism and alcoholic liver disease. Kobayashi C, Kurohane K, Imai Y. High dose dietary pyridoxine induces T-helper type 1 polarization and decreases contact hypersensitivity response to fluorescein isothiocyanate in mice. Rao DB, Jortner BS, Sills RC. Animal models of peripheral neuropathy due to environmental toxicants. Albersen M, Bosma M, Knoers NV, et al. The intestine plays a substantial role in human vitamin B6 metabolism: a Caco-2 cell model. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. Aug 25 1983;309(8):445-448. Gdynia HJ, Muller T, Sperfeld AD, et al. Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6.